PBM Power Map: How Pharmacy Benefit Managers Control Drug Pricing, Formulary Access, and the $700 Billion Prescription Drug Market
Who actually controls what a drug costs at the pharmacy counter? It is not the manufacturer who sets the list […]
Insights
The Pharma Procurement Drain: A Technical Audit of the Mistakes Costing the Industry Billions
Executive Summary Pharmaceutical procurement costs at the average U.S. hospital nearly doubled between 2014 and 2021, climbing from $10.21 million
Drug Patent Intelligence for Out-Licensing: The Definitive Playbook for Pharma BD Teams
The difference between a licensing deal that captures peak asset value and one that leaves money on the table often
Drug Patent Intelligence for Out-Licensing: The Definitive Playbook for Pharma BD Teams Read Post »
Quantitative Methods for Drug Portfolio Optimization: The Complete Technical Guide for Pharma IP Teams, R&D Leads, and Institutional Investors
1. The Economics of Pharmaceutical Portfolio Failure Why Portfolio Optimization Is Not Optional Pharmaceutical R&D is among the most capital-intensive
Pharmaceutical Patent Due Diligence in M&A: The Definitive Analyst’s Guide to IP Valuation, Risk Quantification, and Deal Architecture
Part I: The Strategic Logic of Patent Due Diligence Why Pharma IP Is the Business, Not Just an Asset In
Patent Box Tax Strategy for Pharma: The Complete IP & Investment Playbook
Every blockbuster drug carries two distinct asset classes: the molecule itself and the legal monopoly wrapped around it. The Patent
Patent Box Tax Strategy for Pharma: The Complete IP & Investment Playbook Read Post »
A Comprehensive Guide to Predicting Drug Market Potential
Introduction: Beyond the Crystal Ball – Forging Competitive Advantage in Pharma In the high-stakes world of pharmaceutical innovation, the chasm
A Comprehensive Guide to Predicting Drug Market Potential Read Post »
Exploring the Role of South Africa in the Global Pharmaceutical Landscape
Strategic Analysis of the South African Pharmaceutical Landscape The South African pharmaceutical market is the primary industrial and regulatory anchor
Exploring the Role of South Africa in the Global Pharmaceutical Landscape Read Post »
The Unbundling of the Apothecary: How Vertically Integrated Telehealth Is Dismantling the Pharmaceutical Value Chain
1. The Structural Dissolution of the Traditional Supply Chain The pharmaceutical industry has long relied on a fortress of opacity.
